Trioxacarcin A Interactions with G-Quadruplex DNA Reveal Its Potential New Targets as an Anticancer Agent

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Biochemistry

Background:

• Trioxacarcin A (TXN A) is an anticancer agent known to alkylate double-stranded DNA (dsDNA).
• G-quadruplex DNA (G4-DNA) structures are prevalent in oncogene promoters and telomeres, making them attractive targets for cancer therapy.
• The interaction between TXN A and G4-DNA has not been previously investigated.

Purpose of the Study:

• To investigate the interaction of Trioxacarcin A (TXN A) with various G-quadruplex DNA (G4-DNA) structures.
• To elucidate the specific binding and alkylation sites of TXN A on G4-DNA.
• To understand how TXN A binding affects G4-DNA conformation and stability.

Main Methods:

• Testing TXN A's interaction with parallel, antiparallel, and hybrid G4-DNA oligos.
• Determining the alkylation site preference of TXN A on G4-DNA.
• Structural analysis of TXN A covalently bound to RET G4-DNA.

Main Results:

• TXN A preferentially alkylates a flexible guanine residue located in the loops of parallel G4-DNA.
• The alkylation site on G4-DNA facilitates favorable interactions with TXN A.
• Structural data reveals that TXN A alkylation stabilizes the G4-DNA conformation.

Conclusions:

• TXN A interacts with and alkylates parallel G4-DNA structures.
• The alkylation of G4-DNA by TXN A leads to stabilization of its conformation.
• These findings suggest a novel mechanism for TXN A's anticancer activity involving G4-DNA targeting.